Havisure vaccine

January 22, 2024

India’s first indigenously developed Hepatitis A vaccine ‘Havisure’ was recently launched in Hyderabad.
It has been developed by Hyderabad-based Indian Immunologicals Ltd (IIL), a wholly owned subsidiary of National Dairy Development Board (NDDB) and a leading biopharmaceutical company in India.
This indigenously developed vaccine is poised to play a crucial role in preventing Hepatitis A, a highly contagious liver infection that poses a significant public health challenge.
- Hepatitis A is a viral infection primarily spread through the fecal-oral route, meaning that it is transmitted through the ingestion of contaminated food or water.
It has been reported that the vaccine is effective in preventing the disease and is recommended for children in routine immunization.
It is a two-dose vaccine wherein the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose.
- The vaccine is also recommended for individuals who are at risk of exposure or travel to the regions with high hepatitis A prevalence.
- In addition to this people with occupational risk of infection and suffering from chronic liver diseases also need Hepatitis A vaccination.